Synthesis, characterization, and evaluation of antimicrobial and cytotoxic effect of silver and titanium nanoparticles
Article
-
- Overview
-
- Research
-
- Identity
-
- Additional Document Info
-
- View All
-
Overview
abstract
-
Microbial resistance represents a challenge for the scientific community to develop new bioactive compounds. Nosocomial infections represent an enormous emerging problem, especially in patients with ambulatory treatment, which requires that they wear medical devices for an extended period of time. In this work, an evaluation of the antimicrobial activity of both silver and titanium nanoparticles was carried out against a panel of selected pathogenic and opportunistic microorganisms, some of them commonly associated with device-associated infections. Cytotoxicity assays monitoring DNA damage and cell viability were evaluated using human-derived monocyte cell lines. We show that silver-coated nanoparticles having a size of 20-25 nm were the most effective among all the nanoparticles assayed against the tested microorganisms. In addition, these nanoparticles showed no significant cytotoxicity, suggesting their use as antimicrobial additives in the process of fabrication of ambulatory and nonambulatory medical devices. From the Clinical Editor: In this study, antimicrobial activity of silver and titanium nanoparticles was evaluated against a panel of selected pathogenic and opportunistic microorganisms. Silver-coated nanoparticles of 20-25 nm size were the most effective among all the nanoparticles without significant cytotoxicity, suggesting their use as antimicrobial additives in the process of fabrication of ambulatory and nonambulatory medical devices. © 2010 Elsevier Inc.
publication date
published in
Research
keywords
-
Antimicrobial activity; DNA damage; Nanoparticle toxicity; Silver nanoparticles; Titanium nanoparticles Anti-microbial activity; DNA damage; Nanoparticle toxicity; Silver nanoparticles; Titanium nanoparticles; Biomedical engineering; Cell culture; Cytotoxicity; DNA; Genes; Microorganisms; Nanoparticles; Titanium; Silver; amikacin; amphotericin B; gentamicin; nanoparticle; rifampicin; silver nanoparticle; titanium nanoparticle; unclassified drug; antimicrobial activity; article; cell viability; controlled study; cytotoxicity; device infection; DNA damage; drug screening; drug synthesis; human; human cell; minimum inhibitory concentration; monocyte; nonhuman; Anti-Infective Agents; Bacteria; Cell Line; DNA Damage; Fungi; Humans; Metal Nanoparticles; Microbial Sensitivity Tests; Silver; Titanium
Identity
Digital Object Identifier (DOI)
PubMed ID
Additional Document Info
start page
end page
volume
issue